Royalty Pharma Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio13.2011.01407.0027.6239.23
Forward P/E6.097.4710.3213.0019.16
P/S Ratio5.015.317.797.489.15
P/B Ratio1.101.241.831.671.96
Price/Tangible Book1.631.923.102.974.05
Price/OCF4.094.188.138.489.55
PEG Ratio2.142.650.941.121.97
Enterprise Value Ratios
EV/Revenue9.428.9712.2211.6613.39
EV/EBITDA14.1129.4418.3616.88
EV/EBIT16.5014.1629.6218.6517.11
Profitability & Returns
Return on Equity (ROE)0.13%0.17%0.02%0.12%0.21%
Return on Assets (ROA)0.05%0.06%0.03%0.05%0.07%
Return on Capital Employed (ROCE)0.08%0.09%0.06%0.08%0.11%
Leverage & Solvency Ratios
Debt/Equity0.740.610.750.690.59
Debt/EBITDA4.107.664.883.46
Liquidity Ratios
Current Ratio1.447.902.1916.818.76
Quick Ratio1.437.782.1116.778.73
Efficiency Ratios
Asset Turnover0.130.140.130.140.15
Yield & Distribution Ratios
Earnings Yield0.08%0.09%0.00%0.04%0.05%
Dividend Yield0.03%0.03%0.02%0.02%0.01%
Payout Ratio0.44%0.32%7.78%0.46%0.41%
Buyback Yield0.01%-0.38%-0.06%-0.10%
Total Return0.05%-0.35%-0.04%-0.09%0.01%